Stram D O, Sposto R
Radiation Effects Research Foundation, Hiroshima, Japan.
J Radiat Res. 1991 Mar;32 Suppl:122-35. doi: 10.1269/jrr.32.supplement_122.
Random errors in the DS86 radiation dose estimates used in the analysis of A-bomb survivor data are recognized to have an important impact upon estimates of the risk of late effects such as cancer. Little however is known for certain concerning the distribution of such random errors. This paper gives an overview of recent work at the Radiation Effects Research Foundation (RERF) using multivariate analysis of biological data, including acute effects of radiation exposure, late effects (eg leukemia mortality) and stable chromosome aberrations, for the purpose of evaluating the extent of random error in the estimation of individual doses using DS86. The emphasis here is on analyses of apparent association between biological endpoints, in light of a dosimetry error model framework proposed recently by Pierce et al. Analyses performed to date appear to be consistent with the view that lognormal random dosimetry errors with a standard deviation of 40% or greater of true dose may exist in DS86. Association between radiogenic outcomes in A-bomb survivors, after adjustment for DS86 estimated dose level, has been detected for such widely varying pairs of outcomes as mutant T-cell frequencies and chromosome aberrations, epilation and leukemia mortality, and epilation and chromosome aberrations. The motivation for examining association between pairs of biological endpoints has usually been to determine the extent to which radiation sensitivity varies between individual survivors. Recognizing, however, that random error in dose estimates results in apparent association between biological outcomes is crucial to interpreting studies, such as these, which use data on multiple biological endpoints. To go one step further, in situations where there is a prior knowledge about the biological plausibility of such associations in outcome data the amount of association between radiogenic outcomes (remaining after adjustment for estimated dose), to the extent that they are greater than that assumed to be reasonable, is an important potential source of information concerning the magnitude of random errors in the DS86 dose estimates.
在原子弹幸存者数据分析中使用的DS86辐射剂量估计中的随机误差,被认为对癌症等晚期效应风险的估计有重要影响。然而,关于此类随机误差的分布,确切了解的却很少。本文概述了辐射效应研究基金会(RERF)最近的工作,该工作利用生物数据的多变量分析,包括辐射暴露的急性效应、晚期效应(如白血病死亡率)和稳定染色体畸变,目的是评估使用DS86估计个体剂量时随机误差的程度。这里的重点是根据Pierce等人最近提出的剂量测定误差模型框架,分析生物终点之间的明显关联。迄今为止进行的分析似乎与以下观点一致:DS86中可能存在对数正态随机剂量测定误差,其标准差为真实剂量的40%或更高。在调整DS86估计剂量水平后,已检测到原子弹幸存者中辐射诱发结果之间的关联,这些结果对如突变T细胞频率和染色体畸变、脱毛和白血病死亡率以及脱毛和染色体畸变等差异很大的结果对都成立。检查生物终点对之间关联的动机通常是确定个体幸存者之间辐射敏感性变化的程度。然而,认识到剂量估计中的随机误差会导致生物结果之间出现明显关联,对于解释此类使用多个生物终点数据的研究至关重要。更进一步,在对结果数据中此类关联的生物学合理性有先验知识的情况下,辐射诱发结果之间的关联程度(在调整估计剂量后剩余的),只要它们大于假定合理的程度,就是关于DS86剂量估计中随机误差大小的一个重要潜在信息来源。